Call to Action – House Energy & Commerce Committee Hearings on Mesh

Feb 12th, 2012 | By | Category: Op-Ed

 

Rep. Cliff Stearns (R-Fl)

House Democrats are asking Republicans for a hearing on Johnson & Johnson synthetic surgical transvaginal mesh used to treat pelvic organ prolapse, and the Allergan Lap-Band for weight reduction because of a growing number of patient injuries and a fear that device makers and the U. S. Food and Drug Administration (FDA) may not be protecting patients.

Here is the January 20 letter. So far the hearings have not been scheduled.

On January 23, Rep. Henry Waxman (D-CA) issued a statement:

“The committee should hold hearings to examine whether FDA device regulation has been ineffective in protecting the public from dangerous medical devices like the Lap-Band and intravaginal mesh…“We need to understand the safety of devices on the market, the tactics device manufacturers and others use to market these devices, and the extent to which these tactics may increase risks.”

Rep. Henry Waxman, D-CA along with Democrats Waxman, Reps. John Dingell (D-Michigan) and Diana DeGette (D-CO) want the Republicans on the House Energy and Commerce Committee to revisit a similar request letter last October that asks for hearings on two other controversial medical devices, brain stents and metal-on-metal hip implants. That request was never honored.

The Chairman of the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations, Rep. Cliff Stearns (R-FL) is on record as saying “The medical device industry has brought hundreds of thousands of high-paying jobs to our country and life-saving, life-improving devices to our nation’s patients in a safe and efficient manner.

Remind Rep. Stearns not to forget patient safety as well as the welfare of the medical device industry. Ask these lawmakers to schedule hearings requested by Rep. Waxman for the lap-band and surgical mesh medical devices.

House Energy & Commerce Committee Hearings on Mesh

Rep. Pitts Washington, D.C. office, (202) 225-2411
http://pitts.house.gov/
The Honorable Joseph R. Pitts
Chairman
Subcommittee on Health
2125 Rayburn House Office Building
Washington, DC 20515

Rep. Cliff Stearns Washington, D.C. office (202) 225-5744
http://stearns.house.gov/
The Honorable Cliff Stearns
Chairman
Subcommittee on Oversight and Investigations
2125 Rayburn House Office Building
Washington, DC 2051

Rep. Fred Upton Washington, D.C. office (202) 225-3761
http://upton.house.gov
The Honorable Fred Upton -Chairman
Committee on Energy and Commerce
2125 Rayburn House Office Building
Washington, DC 20515

 

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
Tags:

Leave a Comment

We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.